Latest Updates on GSK
-
Stocks 5 Best Dividend Stocks to Buy Now
There’s no better time than now to invest in dividend stocks.And some of the best dividend stocks that beat the S&P 500’s average yield of 2.00% can be found in the healthcare sector.Global dividends fell by 12.2% in 2020 after the … Read more » -
Currencies The Long and Short of It: There's More Upside as the Dollar Sinks
As the U.S. dollar continues to sink - which is a massive economic trend that we're dealing with currently - our Garrett Baldwin's going to be showing you the many unique, low-risk ways to profit over the next few weeks and beyond... Read more » -
Biotechnology Read This Before You Play a Single One of the Biotechs Fighting COVID-19
Georgia, South Carolina, and Florida have announced that they are loosening quarantine restrictions; at least 13 more states have announced plans or "roadmaps" to do more or less the same thing. There's an urgent desire … Read more » -
Biotechnology How to Cash In on the Biggest Medical Breakthrough of the Decade
Imagine if all it took to treat a case of cancer was taking out the trash. Now, I want you to imagine that your body could do it all for you. Hold that thought. Because a tech platform with that very task in mind is set to hit the … Read more » -
Wall Street This Investing Strategy Is a "Laser-Focused Rocket Ship to Big Profits"
This week I'm spending some time testing the theory from a recent paper on how insider buying and selling affects different bearish and bullish factors. I'm finding that adding insider data to our stable of numbers-driven market strategies … Read more » -
Technology The Answer to Big Pharma's Biggest Problem Could Double Your Money in Just Three Years
You could forgive drug and biotech executives for having a bad case of target fixation. After all, they do work in a field that is filled with time-consuming and expensive headaches. Consider that the Biotechnology Innovation … Read more » -
GlaxoSmithKline Is Now a Top Pharmaceutical Stock to Buy
GlaxoSmithKline doesn't appear to be a top pharmaceutical stock to buy - at least not at first glance. Its shares have underperformed the global pharma sector by 60% over the past decade. But since Glaxo got a new CEO in 2017, the … Read more » -
Dow Jones Dow Jones Industrial Average Rallies Today Ahead of FOMC Decision
The Dow Jones Industrial Average is rallying early Wednesday ahead of today's critical announcement by the Federal Reserve on interest rates. Despite outrage from President Donald Trump, the U.S. central bank is expected to hike interest … Read more » -
Technology This Is Your Next Step to a Biotech Windfall in 2018
The biotech landscape is about to change. Yes, you could invest in a company that might produce a great new treatment. Read more » -
Stocks Why Activision Blizzard, Alphabet, and GlaxoSmithKline Are Stocks to Watch Now
Our latest list of stocks to watch now includes a gaming company with a new e-sports league, an Internet giant solidifying its move into the mobile phone market, and an FDA win for a newly streamlined pharma company. Read more » -
Biotechnology Artificial Intelligence and Biotech Are Merging to Bring You Monster Profits
In biotech, one thing isn't going to change. The "bread and butter" technology that makes up 90% of the pharmaceutical market - good, old-fashioned small molecules, created in the laboratory - isn't going anywhere. Yes, incredibly … Read more » -
Stocks The Best Stocks to Buy Now (and One Stinker to Short)
Our newest list of best stocks to buy now has four picks from tech - from pharmaceuticals and consumer healthcare, to dental technology and the Internet of Everything. Read more » -
Stocks Top Stocks to Watch Today (March 8, 2017): DIS, GSK, EXPR
The top three stocks to watch for today are DIS, GSK, and EXPR. For the first time in six years, the barometer for global economic health has increased by over 9%. Read more » -
Biotechnology 5 Drug Price Increases That Will Have You Seeing Red
Americans need to brace themselves for more drug price increases, as they're not as unusual as you might think. Although the most outrageous drug price hikes, like Turing Pharmaceutical's 5,455% increase in the price of Daraprim, get a lot … Read more »
